Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer

Journal of the National Cancer Institute

Volumn 90, Issue 8, 1998, Pages 587-596

  Gallo, Oreste ^a   Masini, Emanuela ^a   Morbidelli, Lucia ^a   Franchi, Alessandro ^a   Fini Storchi, Isabella ^a   Vergari, William A ^a   Ziche, Marina ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC GMP; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; HEAD AND NECK CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULATURE; TUMOR GROWTH; TUMOR VASCULARIZATION;

EID: 0032522754     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.8.587     Document Type: Article

References (51)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996;46:5-27.
2. Shah JP, Medina JE, Shaha AR, Schantz SP, Marti JR. Cervical lymph node metastasis. Curr Probl Surg 1993;30:1-335.
3. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
4. Barinaga M. Designing therapies that target tumor blood vessels. Science 1997;275:482-4.
5. Fidler IJ, Ellis LM. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 1994;79:185-8.
6. Petruzzelli GJ, Snyderman CH, Johnson JT, Myers EN. Angiogenesis induced by head and neck squamous cell carcinoma xenografts in the chick embryo chorioallantoic membrane model. Ann Otol Rhinol Laryngol 1993;102:215-21.
7. Lingen MW, Polverini PJ, Bouck NP. Retinoic acid induces cells cultured from oral squamous cell carcinomas to become anti-angiogenic. Am J Pathol 1996;149:247-58.
8. Gasparini G, Weidner N, Maluta S, Pozza F, Boracchi P, Mezzetti M, et al. Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous-cell carcinoma. Int J Cancer 1993;55:739-44.
9. Albo D, Granick MS, Jhala N, Atkinson B, Solomon MP. The relationship of angiogenesis to biological activity in human squamous cell carcinomas of the head and neck. Ann Plast Surg 1994;32;588-92.
10. Klijanienko J, el-Naggar AK, de Braud F, Rodriguez-Peralto JL, Rodriguez R, Itzhaki M, et al. Tumor vascularization, mitotic index, histopathologic grade, and DNA ploidy in the assessment of 114 head and neck squamous cell carcinomas. Cancer 1995;75:1649-56.
11. Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moreno V, Moncada S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res 1994;54:1352-4.
12. Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S. Nitric oxide synthase activity in human breast cancer. Br J Cancer 1995;72:41-4.
13. Rosbe KW, Prazma J, Petrusz P, Mims W, Ball SS, Weissler MC. Immunohistochemical characterization of nitric oxide synthase activity in squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 1995;113;541-9.
14. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, et al. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci U S A 1995;92:4392-6.
15. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43;109-42.
16. Nathan C, Xie QW. Nitric oxide synthases: roles, tolls, and controls. Cell 1994;78:915-8.
17. Schmidt HH, Walter U. NO at work. Cell 1994;78:919-25.
18. Morbidelli L, Chang CH, Douglas JG, Granger HJ, Ledda F, Ziche M. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 1996;270:H411-5.
19. Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 1997;99:2625-34.
20. International Union Against Cancer. TNM classification of malignant tumours. Berlin: Springer-Verlag, 1987.
21. Michael L. Squamous cell carcinoma. In: Ferlito A, editor. Surgical pathology of laryngeal neoplasms. London: Chapman & Hall Medical, 1996: 123-42.
22. Bani D, Masini E, Bello MG, Bigazzi M, Bani Sacchi TB. Relaxin activates the L-arginine-nitric oxide pathway in human breast cancer cells. Cancer Res 1995;55:5272-5.
23. Ghigo D, Arese M, Todde R, Vecchi A, Silvagno F, Costamagna C, et al. Middle T antigen-transformed endothelial cells exhibit an increased activity of nitric oxide synthase. J Exp Med 1995;181:9-19.
24. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991; 324:1-8.
25. Ziche M, Gullino PM. Angiogenesis and neoplastic progression in vitro. J Natl Cancer Inst 1982;69:483-7.
26. Ziche M, Alessandri G, Gullino PM. Gangliosides promote the angiogenic response. Lab Invest 1989;61:629-34.
27. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, et al. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 1994;94: 2036-14.
28. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
29. Ziche M, Parenti A, Ledda F, Dell'Era P, Granger HJ, Maggi CA, et al. Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF. Circ Res 1997;80:845-52.
30. Reiling N, Ulmer AJ, Duchrow M, Ernst M, Flad HD, Hauschildt S. Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages. Eur J Immunol 1994;24:1941-4.
31. Ignarro LJ. Signal transduction mechanisms involving nitric oxide. Biochem Pharmacol 1991;41:485-90.
32. Franchi A, Gallo O, Boddi V, Santucci M. Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination. Clin Cancer Res 1996;2:1801-8.
33. Cobbs CS, Brenman JE, Aldape KD, Bredt DS, Israel MA. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res 1995;55:727-30.
34. Villiotou V, Deliconstantinos G. Nitric oxide, peroxynitrite and nitroso-compounds formation by ultraviolet A (UVA) irradiated human squamous cell carcinoma: potential role of nitric oxide in cancer prognosis. Anticancer Res 1995;15:931-42.
35. Jenkins DC, Charles IG, Baylis SA, Lelchuk R, Radomski MW, Moncada S. Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene and nitric oxide generation. Br J Cancer 1994;70: 847-9.
36. Green SJ. Nitric oxide in mucosal immunity [published erratum appears in Nat Med 1995;1:717]. Nat Med 1995;1:515-7.
37. Guo FH, De Raeve HR, Rice TW, Stueher DJ, Thunnissen FB, Erzurum SC. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci U S A 1995; 92:7809-13.
38. Heppner GH. Tumor heterogeneity. Cancer Res 1984;44:2259-65.
39. Dunstan S, Powe DG, Wilkinson M, Pearson J, Hewitt RE. The tumour stroma of oral squamous cell carcinomas show increased vascularity compared with adjacent host tissue. Br J Cancer 1997;75:559-65.
40. Andrade SP, Hart IR, Piper PJ. Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature. Br J Pharmacol 1992;107:1092-5.
41. Tozer GM, Prise VE, Chaplin DJ. Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine. Cancer Res 1997;57:948-55.
42. Vamvakas S, Schmidt HH. Just say NO to cancer? [editorial]. J Natl Cancer Inst 1997:89:406-7.
43. Takahashi M, Fukuda K, Ohata T, Sugimura T, Wakabayashi K. Increased expression of inducible and endothelial constitutive nitric oxide synthases in rat colon tumors induced by azoxymethane. Cancer Res 1997;57: 1233-7.
44. Xie K, Huang S, Dong Z, Juang SH, Wang Y, Fidler IJ. Destruction of bystander cells by tumor cells transfected with inducible nitric oxide (NO) synthase gene. J Natl Cancer Inst 1997;89:421-7.
45. Forrester K, Ambs S, Lupold SE, Kapust RB, Spillare EA, Weinberg WC, et al. Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc Natl Acad Sci U S A 1996;93:2442-7.
46. Dameron KM, Volpert OV, Tainsky MA, Bouck N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 1994; 265:1582-4.
47. Gallo O, Chiarelli I, Bianchi S, Calzolari A, Porfirio B. Loss of the p53 mutation after irradiation is associated with increased aggressiveness in recurred head and neck cancer. Clin Cancer Res 1996;2:1577-83.
48. Tsurumi Y, Murohara T, Krasinski K, Chen D, Witzenbichler B, Kearney M, et al. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med 1997;3:879-86.
49. Sauter E, Nesbit M, Herlyn M. Vascular endothelial growth factor (VEGF) is a marker of disease progression in head and neck cancer [abstract]. Proc Am Assoc Cancer Res 1997;38:331.
50. Inoue K, Ozeki Y, Saganuma T, Sugiura Y, Tanaka S. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression. Cancer 1997; 79: 206-13.
51. 1/2 activation in postcapillary endothelium. J Biol Chem 1998;273:4220-6.